Clinical Trial Update: Dose Dense TC + Pegfilgrastim Support for Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating dose-dense paclitaxel (TC) with pegfilgrastim support in female breast cancer has completed with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• TC (docetaxel + cyclophosphamide) with pegfilgrastim

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Female Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-10-12